Vandetanib: a novel targeted therapy for the treatment of metastatic or locally advanced medullary thyroid cancer.

Pharmacology, Toxicology and Pharmaceutical Science

• Vandetanib 100%
• Thyroid Cancer 100%
• Placebo 33%
• Cardiotoxicity 8%
• Drug Tolerability 8%
• Drug Safety 8%
• Protein Tyrosine Kinase 8%
• Complication 8%
• Adverse Event 8%
• Blindness 8%
• Progression Free Survival 8%
• Headache 8%
• Diarrhea 8%
• Nausea 8%
• Torsade Des Pointes 8%
• Congestive Heart Failure 8%
• Vasculotropin Receptor 8%
• Rash 8%
• Disease 8%
• Pathogenesis 8%
• Hypertension 8%
• Epidermal Growth Factor Receptor 8%
• Long QT Syndrome 8%
• Bradycardia 8%
• Pharmacokinetics 8%